Inhibition of P38 MAP kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion

被引：0
|
作者：
Yue, TL
Sanjay, K
Feng, G
Louden, CS
Wang, C
Gu, JL
Lee, JC
Feuerstein, GZ
Ma, XL
机构：
[1] SmithKline Beecham Pharmaceut, Dept Cardiovasc Pharmacol, King Of Prussia, PA 19406 USA
[2] SmithKline Beecham Pharmaceut, Dept Cellular Biochem, King Of Prussia, PA 19406 USA
[3] SmithKline Beecham Pharmaceut, Dept Toxicol, King Of Prussia, PA 19406 USA
[4] Thomas Jefferson Univ, Div Emergency Med, Philadelphia, PA 19107 USA
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P3632
引用
收藏
页码：R621 / R621
页数：1
相关论文
共 50 条
  • [1] Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion
    Ma, XL
    Kumar, S
    Gao, F
    Louden, CS
    Lopez, BL
    Christopher, TA
    Wang, CL
    Lee, JC
    Feuerstein, GZ
    Yue, TL
    [J]. CIRCULATION, 1999, 99 (13) : 1685 - 1691
  • [2] PD1639016 reduces myocardial ischemia-reperfusion injury by inhibition of the p38 MAP kinase pathway
    Schwertz, H
    Abudureheman, M
    Laengin, T
    Darius, H
    Werdan, K
    Buerke, M
    [J]. FASEB JOURNAL, 2003, 17 (04): : A227 - A227
  • [3] Role of p38 inhibition in cardiac ischemia/reperfusion injury
    Kumphune, Sarawut
    Chattipakorn, Siriporn
    Chattipakorn, Nipon
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) : 513 - 524
  • [4] Role of p38 inhibition in cardiac ischemia/reperfusion injury
    Sarawut Kumphune
    Siriporn Chattipakorn
    Nipon Chattipakorn
    [J]. European Journal of Clinical Pharmacology, 2012, 68 : 513 - 524
  • [5] CARDIAC FIBROBLAST P38α MAP KINASE IS ESSENTIAL FOR CARDIOMYOCYTE HYPERTROPHY AND CARDIAC DYSFUNCTION FOLLOWING MYOCARDIAL INJURY
    Bageghni, S. A.
    Hemmings, K. E.
    Porter, K. E.
    Ainscough, J. F. X.
    Drinkhill, M. J.
    Turner, N. A.
    [J]. HEART, 2016, 102 : A2 - A2
  • [6] Selective inhibition of p38α MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury
    Li, Zhihe
    Ma, Jing Ying
    Kerr, Irene
    Chakravarty, Sarvajit
    Dugar, Sundeep
    Schreiner, George
    Protter, Andrew A.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (04): : H1972 - H1977
  • [7] Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor
    Schwertz, Hansjorg
    Carter, Justin M.
    Abdudureheman, Mulati
    Russ, Martin
    Buerke, Ute
    Schlitt, Axel
    Mueller-Werdan, Ursula
    Prondzinsky, Roland
    Werdan, Karl
    Buerke, Michael
    [J]. PROTEOMICS, 2007, 7 (24) : 4579 - 4588
  • [8] p38 mapk inhibition decreases ischemia induced proinflammatory myocardial injury
    Pitcher, J
    Wang, M
    Tsai, B
    Kher, A
    Meldrum, DR
    [J]. SHOCK, 2005, 23 : 32 - 32
  • [9] G Protein-Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Decreases Ischemia/Reperfusion Induced Myocardial Apoptosis and Improves Cardiac Function
    Gao, Erhe
    Fan, Qian
    Shang, Xiying
    Huang, Zheng
    Raake, Philip
    Chuprun, J. Kurt
    Dorn, Gerald W., II
    Koch, Walter J.
    [J]. CIRCULATION, 2009, 120 (18) : S800 - S800
  • [10] Novel mechanism of cardioprotection by p38 MAPK inhibition in myocardial ischemia and reperfusion
    Ma, XL
    Gao, F
    Lopez, BL
    Christopher, TA
    Ohlstein, EH
    Yue, TL
    [J]. FASEB JOURNAL, 2001, 15 (04): : A464 - A464
12345